JHS Svendgaard Laboratories Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of JHS Svendgaard Laboratories Ltd?

JHS Svendgaard Laboratories Ltd is trading at 9.13 as of 26 April 2026, with a FY2026-2027 high of 16.5 and low of 6.15. The stock is currently in the middle of its 52-week range. Market cap stands at 79.8 Cr..

Q: Is JHS Svendgaard Laboratories Ltd financially healthy?

Key indicators: ROCE of 5.19 % is on the lower side. Dividend yield is 0.00 %.

Q: Is JHS Svendgaard Laboratories Ltd profitable and how is the profit trend?

JHS Svendgaard Laboratories Ltd reported a net profit of -20 Cr in Mar 2025 on revenue of 92 Cr. Compared to -4 Cr in Mar 2022, the net profit shows a mixed trend.

Fair Value

₹26.83Undervalued by 193.87%vs CMP ₹9.13

P/E (15.0) × ROE (10.8%) × BV (₹20.30) × DY (2.00%)

Defaults: P/E=15

₹15.56Undervalued by 70.43%vs CMP ₹9.13

MoS: +41.3% (Strong)Confidence: 40/100 (Low)Models: 3 Under, 2 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹26.83	34%	Under (+193.9%)
Net Asset Value	Assets	₹19.87	20%	Under (+117.6%)
EV/EBITDA	Enterprise	₹3.30	17%	Over (-63.9%)
ROCE Capital	Returns	₹1.88	14%	Over (-79.4%)
Revenue Multiple	Revenue	₹10.53	15%	Under (+15.3%)
Consensus (5 models)		₹15.56	100%	Undervalued

Key Drivers: Wide model spread (₹2–₹27) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 0.0% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

JHS Svendgaard Laboratories Ltd operates in the Personal Care segment, current market price is ₹9.13, market cap is 79.8 Cr.. At a glance, ROE is 10.8 %, ROCE is 5.19 %, book value is 20.3, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹15.56, which is about 70.4% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹92 Cr versus the prior period change of 29.9%, while latest net profit is about ₹-20 Cr with a prior-period change of -386.2%. The 52-week range shown on this page is 16.5/6.15, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisJHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification…

This summary is generated from the stock page data available for JHS Svendgaard Laboratories Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

JHS Svendgaard Laboratories Ltd scores 57/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health45/100 · Moderate

ROCE 5.2% WeakROE 10.8% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent

Smart Money70/100 · Strong

FII holding up 2.01% (6mo) AccumulatingPromoter holding at 33.9% Stable

Earnings Quality75/100 · Strong

OPM expanding (-6% → -3%) ImprovingWorking capital: 48 days (improving) Efficient

Quarterly Momentum70/100 · Strong

Revenue (4Q): +6% YoY GrowingOPM: 7.2% (up 6.1% YoY) Margin expansion

Industry Rank25/100 · Weak

ROCE 5.2% vs industry 29.9% Below peersROE 10.8% vs industry 24.6% Below peers3Y sales CAGR: 2% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 25, 2026, 10:53 pm

Market Cap	79.8 Cr.
Current Price	9.13
Intrinsic Value	₹15.56
High / Low	16.5/6.15
Stock P/E
Book Value	20.3
Dividend Yield	0.00 %
ROCE	5.19 %
ROE	10.8 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for JHS Svendgaard Laboratories Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Honasa Consumer Ltd	11,351 Cr.	349	360/228	73.4	38.8	0.00 %	7.44 %	5.51 %	10.0
Ambica Agarbathies Aroma & Industries Ltd	41.1 Cr.	23.9	32.9/20.0	59.6	65.2	0.00 %	7.49 %	0.45 %	10.0
Ador Multi Products Ltd	140 Cr.	123	149/66.6		32.5	0.00 %	11.4 %	3.09 %	10.0
Kaya Ltd	399 Cr.	263	488/228		60.9	0.00 %	2.50 %	%	10.0
Jyothy Labs Ltd	9,511 Cr.	259	389/196	26.0	55.8	1.35 %	24.6 %	19.0 %	1.00
Industry Average	68,086.14 Cr	1,717.44		54.35	112.52	0.90%	29.93%	24.55%	4.94

All Competitor Stocks of JHS Svendgaard Laboratories Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	22.19	21.72	15.90	18.93	14.30	21.66	24.48	19.68	22.66	25.17	23.45	22.28	23.27
Expenses	24.41	25.28	18.02	18.52	14.36	20.82	22.51	20.52	22.41	30.55	21.79	21.37	21.60
Operating Profit	-2.22	-3.56	-2.12	0.41	-0.06	0.84	1.97	-0.84	0.25	-5.38	1.66	0.91	1.67
OPM %	-10.00%	-16.39%	-13.33%	2.17%	-0.42%	3.88%	8.05%	-4.27%	1.10%	-21.37%	7.08%	4.08%	7.18%
Other Income	0.94	-11.54	0.41	0.20	2.34	1.37	0.32	0.86	0.27	-1.44	1.00	1.14	0.59
Interest	0.16	0.11	0.13	0.10	0.11	0.13	0.12	0.11	0.13	0.21	0.16	0.20	0.28
Depreciation	1.46	1.61	1.32	1.50	1.63	1.90	1.97	1.98	1.97	2.02	1.88	1.86	1.90
Profit before tax	-2.90	-16.82	-3.16	-0.99	0.54	0.18	0.20	-2.07	-1.58	-9.05	0.62	-0.01	0.08
Tax %	-4.83%	-36.39%	-18.35%	-26.26%	100.00%	516.67%	415.00%	398.07%	15.82%	-23.09%	-69.35%	1,800.00%	-887.50%
Net Profit	-2.76	-10.71	-2.59	-0.73	0.01	-0.75	-0.63	-10.32	-1.84	-6.96	1.06	-0.20	0.79
EPS in Rs	-0.43	-1.65	-0.40	-0.09	0.00	-0.10	-0.08	-1.21	-0.21	-0.81	0.12	-0.02	0.09

Last Updated: March 4, 2026, 7:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 4:16 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	35.28	55.10	99.62	104.18	140.29	123.99	139.11	100.77	86.25	84.81	70.80	92.00	94.17
Expenses	39.06	58.95	93.11	92.45	126.34	123.89	137.40	98.80	87.09	93.88	71.73	96.01	95.31
Operating Profit	-3.78	-3.85	6.51	11.73	13.95	0.10	1.71	1.97	-0.84	-9.07	-0.93	-4.01	-1.14
OPM %	-10.71%	-6.99%	6.53%	11.26%	9.94%	0.08%	1.23%	1.95%	-0.97%	-10.69%	-1.31%	-4.36%	-1.21%
Other Income	-2.67	-5.79	-17.30	0.39	32.03	5.97	3.16	7.49	9.39	-7.31	4.31	0.02	1.29
Interest	14.14	0.14	0.36	0.62	0.74	1.03	1.95	1.24	1.39	0.55	0.46	0.57	0.85
Depreciation	14.71	12.36	10.49	6.36	6.81	7.09	8.76	7.25	7.05	6.02	6.35	7.95	7.66
Profit before tax	-35.30	-22.14	-21.64	5.14	38.43	-2.05	-5.84	0.97	0.11	-22.95	-3.43	-12.51	-8.36
Tax %	-18.39%	0.18%	0.00%	-326.85%	32.19%	-18.54%	-16.95%	-39.18%	4,000.00%	-23.66%	18.37%	57.87%
Net Profit	-28.81	-22.18	-21.64	21.94	26.06	-1.67	-4.86	1.34	-4.29	-17.52	-4.06	-19.74	-5.31
EPS in Rs	-11.95	-9.20	-5.76	4.98	4.29	-0.11	-0.33	0.19	-0.62	0.62	-0.52	-2.31	-0.62
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	23.01%	2.43%	201.39%	18.78%	-106.41%	-191.02%	127.57%	-420.15%	-308.39%	76.83%	-386.21%
Change in YoY Net Profit Growth (%)	0.00%	-20.58%	198.95%	-182.61%	-125.19%	-84.61%	318.59%	-547.72%	111.76%	385.22%	-463.03%

JHS Svendgaard Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	-8%
3 Years:	2%
TTM:	15%

Compounded Profit Growth
10 Years:	-2%
5 Years:	%
3 Years:	%
TTM:	-624%

Stock Price CAGR
10 Years:	0%
5 Years:	-9%
3 Years:	-23%
1 Year:	-61%

Return on Equity
10 Years:	2%
5 Years:	0%
3 Years:	0%
Last Year:	-11%

Last Updated: September 5, 2025, 8:15 am

Balance Sheet

Last Updated: December 10, 2025, 2:54 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	24.10	24.10	37.64	44.12	60.90	60.90	60.90	64.40	64.90	78.40	78.40	85.60	85.60
Reserves	38.01	95.50	62.95	90.25	113.36	115.94	117.10	124.30	121.00	95.44	91.49	87.12	88.04
Borrowings	54.12	18.82	2.56	2.31	2.49	7.19	8.58	7.01	6.19	2.58	5.13	6.46	10.59
Other Liabilities	74.19	32.93	19.26	18.57	31.59	38.54	54.88	32.72	30.01	51.81	22.04	24.62	22.67
Total Liabilities	190.42	171.35	122.41	155.25	208.34	222.57	241.46	228.43	222.10	228.23	197.06	203.80	206.90
Fixed Assets	120.88	107.89	65.10	65.00	71.41	70.81	65.63	63.22	58.52	65.07	90.41	90.33	88.32
CWIP	0.03	0.03	0.68	0.67	0.51	4.80	7.05	8.92	19.96	8.57	0.82	0.00	2.95
Investments	0.00	0.00	0.00	1.03	18.19	9.75	6.03	2.05	3.62	2.97	3.45	3.64	4.88
Other Assets	69.51	63.43	56.63	88.55	118.23	137.21	162.75	154.24	140.00	151.62	102.38	109.83	110.75
Total Assets	190.42	171.35	122.41	155.25	208.34	222.57	241.46	228.43	222.10	228.23	197.06	203.80	206.90

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	28.17	7.29	-3.77	-3.93	13.80	-10.79	10.35	12.03	-9.14	23.29	-9.18	-5.18
Cash from Investing Activity +	2.74	1.32	1.48	-3.36	-27.02	-6.87	-10.97	-2.23	-4.70	9.68	-21.14	-20.25
Cash from Financing Activity +	-29.14	-9.75	4.21	10.11	13.63	12.53	0.49	10.31	-1.67	-0.64	2.17	23.07
Net Cash Flow	1.77	-1.13	1.92	2.83	0.42	-5.13	-0.13	20.11	-15.50	32.33	-28.14	-2.36
Free Cash Flow	30.64	8.53	-6.59	-16.64	3.42	-26.37	0.11	5.43	-15.54	20.71	-32.91	-14.43
CFO/OP	-748%	-189%	-58%	-33%	119%	-10,000%	595%	650%	1,051%	-257%	1,001%	122%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-57.90	-22.67	3.95	9.42	11.46	-7.09	-6.87	-5.04	-7.03	-11.65	-6.06	-10.47

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	188	167	25	48	111	158	252	213	77	80	66	52
Inventory Days	122	94	53	95	65	60	30	97	114	128	176	153
Days Payable	95	106	67	123	153	134	177	128	130	197	197	141
Cash Conversion Cycle	215	156	12	19	23	85	105	182	61	11	46	63
Working Capital Days	-708	-39	58	56	122	173	198	272	217	41	51	48
ROCE %	-10%	-12%	-3%	5%	8%	-0%	4%	1%	1%	-2%	-2%	-5%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Feb 2026
Promoters	42.23%	37.73%	37.73%	37.73%	37.73%	34.56%	34.56%	34.56%	34.56%	34.56%	34.56%	33.85%
FIIs	0.00%	0.00%	0.00%	2.29%	0.15%	1.69%	1.59%	1.60%	1.59%	1.57%	1.57%	3.60%
DIIs	0.00%	0.00%	9.16%	6.21%	6.05%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	57.78%	62.25%	53.10%	53.75%	56.05%	63.76%	63.85%	63.84%	63.86%	63.87%	63.86%	62.56%
No. of Shareholders	23,800	22,794	22,648	26,448	25,768	25,994	26,276	25,567	25,155	25,007	25,151	25,377

Shareholding Pattern Chart

No. of Shareholders

JHS Svendgaard Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-2.37	-0.52	-2.34	-0.63	0.20
Diluted EPS (Rs.)	-2.37	-0.52	-2.34	-0.63	0.20
Cash EPS (Rs.)	-1.38	0.29	-1.43	0.42	1.33
Book Value[Excl.RevalReserv]/Share (Rs.)	20.18	21.67	27.78	30.05	30.74
Book Value[Incl.RevalReserv]/Share (Rs.)	20.18	21.67	27.78	30.05	30.74
Revenue From Operations / Share (Rs.)	10.75	9.03	14.82	13.29	15.65
PBDIT / Share (Rs.)	-0.13	0.43	0.81	1.32	1.47
PBIT / Share (Rs.)	-1.06	-0.37	-0.33	0.23	0.34
PBT / Share (Rs.)	-1.46	-0.43	-3.37	0.01	0.15
Net Profit / Share (Rs.)	-2.31	-0.51	-2.58	-0.66	0.20
NP After MI And SOA / Share (Rs.)	-2.31	-0.51	-2.38	-0.62	0.18
PBDIT Margin (%)	-1.23	4.77	5.50	9.91	9.39
PBIT Margin (%)	-9.87	-4.19	-2.25	1.73	2.19
PBT Margin (%)	-13.59	-4.84	-22.70	0.11	0.96
Net Profit Margin (%)	-21.46	-5.73	-17.43	-4.97	1.33
NP After MI And SOA Margin (%)	-21.46	-5.73	-16.07	-4.69	1.18
Return on Networth / Equity (%)	-11.43	-2.38	-8.96	-2.17	0.63
Return on Capital Employeed (%)	-5.14	-1.70	-1.09	0.73	1.07
Return On Assets (%)	-9.81	-2.05	-6.54	-1.82	0.52
Total Debt / Equity (X)	0.02	0.02	0.00	0.00	0.00
Asset Turnover Ratio (%)	0.46	0.32	0.41	0.36	0.42
Current Ratio (X)	2.18	1.87	2.36	4.18	5.23
Quick Ratio (X)	1.70	1.33	2.00	3.54	4.73
Inventory Turnover Ratio (X)	7.50	3.11	4.36	5.16	8.94
Interest Coverage Ratio (X)	-2.01	7.34	5.09	6.13	7.63
Interest Coverage Ratio (Post Tax) (X)	-28.88	-7.82	2.78	-2.08	2.08
Enterprise Value (Cr.)	81.22	121.69	70.51	136.74	117.07
EV / Net Operating Revenue (X)	0.88	1.72	0.73	1.59	1.16
EV / EBITDA (X)	-71.68	36.03	13.31	15.99	12.37
MarketCap / Net Operating Revenue (X)	1.04	1.81	1.06	1.55	1.27
Price / BV (X)	0.55	0.75	0.59	0.71	0.68
Price / Net Operating Revenue (X)	1.04	1.81	1.06	1.55	1.27
EarningsYield	-0.20	-0.03	-0.15	-0.03	0.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

JHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L74110HP2004PLC027558 and registration number is 027558. Currently company belongs to the Industry of Personal Care. Company's Total Operating Revenue is Rs. 92.00 Cr. and Equity Capital is Rs. 85.60 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Personal Care	Trilokpur Road, Kheri (Kala Amb), Sirmour Dist. Himachal Pradesh 173030	Contact not found

Management
Name	Position Held
Mr. Rajagopal Chakravarthi Venkateish	Chairman & Ind.Director
Mr. Nikhil Nanda	Managing & Executive Director
Mr. Vinay Mittal	Non Executive Director
Mr. Kapil Minocha	Independent Director
Mrs. Upma Chawdhry	Independent Woman Director

FAQ

What is the intrinsic value of JHS Svendgaard Laboratories Ltd and is it undervalued?

As of 26 April 2026, JHS Svendgaard Laboratories Ltd's intrinsic value is ₹15.56, which is 70.43% higher than the current market price of ₹9.13, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (10.8 %), book value (₹20.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of JHS Svendgaard Laboratories Ltd?

JHS Svendgaard Laboratories Ltd is trading at ₹9.13 as of 26 April 2026, with a FY2026-2027 high of ₹16.5 and low of ₹6.15. The stock is currently in the middle of its 52-week range. Market cap stands at ₹79.8 Cr..

How does JHS Svendgaard Laboratories Ltd's P/E ratio compare to its industry?

JHS Svendgaard Laboratories Ltd has a P/E ratio of , which is below the industry average of 54.35. This is broadly in line with or below the industry average.

Is JHS Svendgaard Laboratories Ltd financially healthy?

Key indicators for JHS Svendgaard Laboratories Ltd: ROCE of 5.19 % is on the lower side compared to the industry average of 29.93%. Dividend yield is 0.00 %.

Is JHS Svendgaard Laboratories Ltd profitable and how is the profit trend?

JHS Svendgaard Laboratories Ltd reported a net profit of ₹-20 Cr in Mar 2025 on revenue of ₹92 Cr. Compared to ₹-4 Cr in Mar 2022, the net profit shows a mixed trend.

Does JHS Svendgaard Laboratories Ltd pay dividends?

JHS Svendgaard Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹9.13. The company is currently not paying meaningful dividends.